Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Pushes Back GSK’s Momelotinib Decision

Ruling Now Expected By 16 September

Jun 16 2023

• By Andrew McConaghie

• Source: GSK

Related Content

GSK’s Arexvy Is First RSV Vaccine Approved By FDA, But A Second Is Poised To Follow

May 03 2023

Related Companies

GSK plc

Novartis AG

Incyte Corporation

Bristol Myers Squibb Company

CTI BioPharma Corp.

Sierra Oncology, Inc.

Pfizer Inc.

Additional Topics

Regulation FDA Companies Blood & Coagulation Disorders Cancer BioPharmaceutical

More from Blood and Clotting

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window